Estimating the Test-adjusted Incidence of Infections Identified Through Public Health Ontario Laboratories in Peel Region, Ontario, 2010-2018: a Population-based Study

Overview

Journal CMAJ Open

Specialty General Medicine

Date 2023 Jan 24

PMID 36693657

Authors

Lindsay Obress

Olaf Berke

David N Fisman

Shilpa Raju

Ashleigh R Tuite

Monali Varia

Amy L Greer

Affiliations

Soon will be listed here.

Abstract

Background: Public health guidelines for chlamydia testing are not sex specific, but young females test at a disproportionally higher rate than males and other age groups. This study aims to describe testing trends across age and sex subgroups, then estimate a test-adjusted incidence of chlamydia in these subgroups to identify gaps in current testing practices.

Methods: We used a population-based study to examine observed chlamydia rates by age and sex subgroups: 15-19 years, 20-29 years, 30-39 years and older than 40 years. The study included diagnostic test results recorded by Public Health Ontario Laboratories between Jan. 1, 2010, and Dec. 31, 2018, for individuals living in Peel region, Ontario. We then employed meta-regression models as a method of standardization to estimate the effect of sex and age on standardized morbidity ratio, testing ratio and test positivity, then calculate a test-adjusted incidence of chlamydia for each subgroup.

Results: Over the study period, infection, testing and test positivity varied across age and sex subgroups. Observed incidence and testing were highest in females aged 20-29 years, whereas males had the highest standardized test positivity across all age groups. After estimating test-adjusted incidence for each age-sex subgroup, males in the 15-19-year and 30-39-year age groups had an increase in incidence of 60.2% and 9.7%, respectively, compared with the observed incidence.

Interpretation: We found that estimated test-adjusted incidence was higher than observed incidence in males aged 15-19 years and 30-39 years. This suggests that infections in males are likely being missed owing to differential testing, and this may be contributing to the persistent increase in reported cases in Canada. Public health programming that targets males, especially in high-risk settings and communities, and use of innovative partner notification methods could be critical to curbing overall rates of chlamydia.

References

Fisman D, Greer A, Brankston G, Hillmer M, OBrien S, Drews S . COVID-19 Case Age Distribution: Correction for Differential Testing by Age. Ann Intern Med. 2021; 174(10):1430-1438. PMC: 8381772. DOI: 10.7326/M20-7003. View

Mishori R, McClaskey E, WinklerPrins V . Chlamydia trachomatis infections: screening, diagnosis, and management. Am Fam Physician. 2013; 86(12):1127-32. View

Wilson E, Free C, Morris T, Syred J, Ahamed I, Menon-Johansson A . Internet-accessed sexually transmitted infection (e-STI) testing and results service: A randomised, single-blind, controlled trial. PLoS Med. 2017; 14(12):e1002479. PMC: 5744909. DOI: 10.1371/journal.pmed.1002479. View

Moore A, Traversy G, Reynolds D, Riva J, Theriault G, Wilson B . Recommendation on screening for chlamydia and gonorrhea in primary care for individuals not known to be at high risk. CMAJ. 2021; 193(16):E549-E559. PMC: 8084554. DOI: 10.1503/cmaj.201967. View

Matheson F, Smith K, Fazli G, Moineddin R, Dunn J, Glazier R . Physical health and gender as risk factors for usage of services for mental illness. J Epidemiol Community Health. 2014; 68(10):971-8. PMC: 4174114. DOI: 10.1136/jech-2014-203844. View

Golden M, Whittington W, Handsfield H, Hughes J, Stamm W, Hogben M . Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med. 2005; 352(7):676-85. DOI: 10.1056/NEJMoa041681. View

Choudhri Y, Miller J, Sandhu J, Leon A, Aho J . Chlamydia in Canada, 2010-2015. Can Commun Dis Rep. 2018; 44(2):49-54. PMC: 5864312. DOI: 10.14745/ccdr.v44i02a03. View

Thompson A, Anisimowicz Y, Miedema B, Hogg W, Wodchis W, Aubrey-Bassler K . The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study. BMC Fam Pract. 2016; 17:38. PMC: 4815064. DOI: 10.1186/s12875-016-0440-0. View

Benchimol E, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I . The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015; 12(10):e1001885. PMC: 4595218. DOI: 10.1371/journal.pmed.1001885. View

10.

Guerry S, Bauer H, Packel L, Samuel M, Chow J, Rhew M . Chlamydia screening and management practices of primary care physicians and nurse practitioners in California. J Gen Intern Med. 2006; 20(12):1102-7. PMC: 1490271. DOI: 10.1111/j.1525-1497.2005.00240.x. View

11.

Gilbert M, Salway T, Haag D, Elliot E, Fairley C, Krajden M . A cohort study comparing rate of repeat testing for sexually transmitted and blood-borne infections between clients of an internet-based testing programme and of sexually transmitted infection clinics in Vancouver, Canada. Sex Transm Infect. 2019; 95(7):540-546. PMC: 6860414. DOI: 10.1136/sextrans-2019-054071. View

12.

Masaro C, Johnson J, Chabot C, Shoveller J . STI service delivery in British Columbia, Canada; providers' views of their services to youth. BMC Health Serv Res. 2012; 12:240. PMC: 3469370. DOI: 10.1186/1472-6963-12-240. View

13.

Pujalte G, Effiong I, Nishi L, Clapp A, Waller T . Primary Care Perceptions and Practices on Discussion and Advice Regarding Sexual Practices. South Med J. 2020; 113(7):356-359. DOI: 10.14423/SMJ.0000000000001114. View

14.

Workowski K, Bolan G . Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015; 64(RR-03):1-137. PMC: 5885289. View

15.

Tao G, Irwin K . Receipt of HIV and STD testing services during routine general medical or gynecological examinations: variations by patient sexual risk behaviors. Sex Transm Dis. 2007; 35(2):167-71. DOI: 10.1097/OLQ.0b013e3181585be5. View

16.

Machalek K, Hanley B, Kajiwara J, Pasquali P, Stannard C . Chlamydia screening practices among physicians and community nurses in Yukon, Canada. Int J Circumpolar Health. 2013; 72. PMC: 3753158. DOI: 10.3402/ijch.v72i0.21607. View

17.

Gift T, Gaydos C, Kent C, Marrazzo J, Rietmeijer C, Schillinger J . The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women. Sex Transm Dis. 2008; 35(11 Suppl):S66-75. DOI: 10.1097/OLQ.0b013e31818b64ac. View

18.

Gopalappa C, Huang Y, Gift T, Owusu-Edusei K, Taylor M, Gales V . Cost-effectiveness of screening men in Maricopa County jails for chlamydia and gonorrhea to avert infections in women. Sex Transm Dis. 2013; 40(10):776-83. PMC: 4591034. DOI: 10.1097/OLQ.0000000000000023. View

19.

MacKinnon K, Mykhalovskiy E, Worthington C, Gomez-Ramirez O, Gilbert M, Grace D . Pay to skip the line: The political economy of digital testing services for HIV and other sexually transmitted infections. Soc Sci Med. 2020; 268:113571. DOI: 10.1016/j.socscimed.2020.113571. View

20.

Gilbert M, Haag D, Hottes T, Bondyra M, Elliot E, Chabot C . Get Checked… Where? The Development of a Comprehensive, Integrated Internet-Based Testing Program for Sexually Transmitted and Blood-Borne Infections in British Columbia, Canada. JMIR Res Protoc. 2016; 5(3):e186. PMC: 5050385. DOI: 10.2196/resprot.6293. View